Potassium Carbonate → HCID 24936355, compound
Reaction equation
[F:1][C:2]1[CH:10]=[C:9]2[C:5]([CH:6]=[CH:7][N:8]2S(C2C=CC(C)=CC=2)(=O)=O)=[C:4]([C:21]2[N:22]=[C:23]([N:42]3[CH2:47][CH2:46][O:45][CH2:44][CH2:43]3)[C:24]3[S:29][C:28]([CH2:30]OS(C4C=CC(C)=CC=4)(=O)=O)=[CH:27][C:25]=3[N:26]=2)[CH:3]=1.C(=O)([O-])[O-].[K+].[K+].[CH3:54][C@H:55]1[CH2:60][NH:59][CH2:58][C@@H:57]([CH3:61])[NH:56]1.[OH-].[Na+].[Cl-].[NH4+]>CN(C=O)C.C(Cl)Cl.O>[CH3:54][C@H:55]1[NH:56][C@@H:57]([CH3:61])[CH2:58][N:59]([CH2:30][C:28]2[S:29][C:24]3[C:23]([N:42]4[CH2:43][CH2:44][O:45][CH2:46][CH2:47]4)=[N:22][C:21]([C:4]4[CH:3]=[C:2]([F:1])[CH:10]=[C:9]5[C:5]=4[CH:6]=[CH:7][NH:8]5)=[N:26][C:25]=3[CH:27]=2)[CH2:60]1Participants
9
Reactant 5
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of toluene-4-sulfonic acid 2-[6-fluoro-1-(toluene-4-sulfonyl)-1H-indol-4-yl]-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-ylmethyl ester (100 mg, 0.144 mmol) in DMF (1 mL) were added potassium carbonate (100 mg, 0.724 mmol) and (cis)-2,6-dimethyl-piperazine (33 mg, 0.289 mmol). The reaction mixture was stirred at RT for 2 h before water and DCM were added. The phases were separated using a hydrophobic frit and the organic phase was concentrated in vacuo. The resultant residue was dissolved in dioxane (1 mL) and IMS (1 mL), and an aqueous solution of NaOH (12 M, 1 mL, 12 mmol) was added. The mixture was stirred at RT for 3 h before a sat. aqueous solution of ammonium chloride and DCM were added.
Workup
- additionwere added
- customThe phases were separated
- concentrationthe organic phase was concentrated in vacuo
- dissolutionThe resultant residue was dissolved in dioxane (1 mL)
- additionwere added
Sources & evidence
- ORD record
- ord-855dfabee431499fa31b4447bb13ba61
- Source dataset
- uspto-grants-2012_08
- Patent number
- US08252792B2
Reaction notes
Loading…